The Daily Toke

# Cannabis Policy Hits a Crossroads: Legal Progress Clashes With Political Resistance

Florida's cannabis legalization effort just died in court, but the real story isn't what happened in one state—it's the contradictory mess happening across the country right now. According to Marijuana Moment, the Florida Supreme Court rejected a legalization campaign's appeal to restore rejected signatures, effectively killing the 2026 ballot initiative. But while Florida slams the door shut, other states are throwing it wide open. Tennessee is relaunching its "Pot for Potholes" campaign to legalize recreational cannabis and fund infrastructure, Minnesota just approved regulated psilocybin therapy, and Georgia's House passed bipartisan legislation to modernize medical cannabis access. 🚀 THIS IS COOL A new study from Columbia University, as Medical Xpress reported, shows that recreational cannabis laws—beyond just medical programs—actually shrink the illegal market. So why are some states moving forward while others are moving backward?

Enter Oklahoma's governor, who's making a bold political gamble. According to Marijuana Moment, Gov. Kevin Stitt is pushing hard to roll back the state's voter-approved medical cannabis program, claiming Oklahomans were "sold a bill of goods" in 2018. His argument: there are now more dispensaries than pharmacies, the state grows 32 times more cannabis than is consumed legally, and cartel activity has infiltrated the market. But here's where it gets interesting—his own party is hesitant. Senate President Pro Tempore Lonnie Paxton, a Republican, came out and said it would be "really hard to completely undo" legalization after licensed operators invested their life savings into the program. "It's hard to unring that bell," he said. This is the fundamental tension in cannabis politics right now: voter-approved programs, once implemented, are extremely difficult to dismantle—even when a governor wants them gone.

Meanwhile, Congress is quietly moving to restrict cannabis advertising in ways that could reshape how legal businesses operate. According to Marijuana Moment, the House Energy and Commerce Committee just passed the Kids Internet and Digital Safety (KIDS) Act, which would prohibit online platforms from advertising cannabis products to minors. On the surface, that sounds reasonable—who doesn't want to protect kids? But 🔎 DOUBLE STANDARD WATCH alcohol is advertised during every major sporting event that millions of teenagers watch, yet alcohol kills approximately 95,000 Americans annually. Cannabis: zero overdose deaths in recorded history. Which product are we actually regulating to protect children, and which one are we just regulating cannabis-sized businesses? The bill targets cannabis, tobacco, and narcotics the same way, lumping a zero-death plant in with substances that cause mass harm.

The federal picture is getting messier. According to Reuters, the 9th Circuit Court just ruled that the Dormant Commerce Clause—a constitutional principle that prevents states from favoring local commerce over interstate commerce—does not apply to cannabis. This creates a circuit split and opens the door for states to regulate cannabis markets however they want without federal commerce law constraints. Meanwhile, as Marijuana Moment reported, Senator Jeff Merkley (D-OR) filed an amendment to help cannabis industry workers qualify for federally backed mortgage loans by treating cannabis income like any other legal income. 💰 MONEY MOVES It's a small but significant step toward normalizing the industry's financial legitimacy—workers in legal cannabis shouldn't be denied mortgages because of where they work.

Some states are getting creative with cannabis policy beyond just legalization. According to Marijuana Moment, Arizona's Senate passed a bill that would punish people for creating "excessive" marijuana smoke or odor, making it punishable by up to four months in jail and a $750 fine if conduct is intentional or substantially interferes with neighbors' property enjoyment. Colorado is allowing terminally ill patients to use medical cannabis in hospitals, and Hawaii just approved a psychedelics task force to study psilocybin and MDMA access. But New Hampshire chose a different path—according to Marijuana Moment, the House simply let bills to legalize marijuana and authorize psilocybin therapy die without a floor vote. No dramatic rejection—just procedural death.

The larger pattern here is striking: cannabis is becoming normalized in ways that go beyond simple legalization. States aren't just asking whether cannabis should be legal; they're asking how to regulate it, tax it, use it therapeutically, and integrate workers into financial systems. 🤔 THINK ABOUT IT If recreational cannabis laws actually shrink the illegal market—as that Columbia study shows—and if cannabis has never killed anyone through overdose while alcohol kills 95,000 Americans annually, why are some states still moving backward? Why is Oklahoma's governor trying to undo a voter-approved program while other states are building regulatory frameworks? Why is Congress restricting cannabis advertising while alcohol dominates prime-time television? The conversation isn't whether cannabis should exist anymore. The conversation is about how to manage its existence—and that's the conversation we should have been having fifty years ago.

# Hemp Ban Watch: A Multi-State Crackdown That Defies Logic

Three weeks. That's all Texas hemp retailers have left before the state effectively bans smokable cannabis products—the most popular item in their inventory. According to Yahoo News, the Texas Department of State Health Services finalized new rules on March 6 that redefine how the state measures THC content in hemp products. Instead of testing only delta-9 THC (the main psychoactive compound), the state will now measure total THC—including THCA, a non-intoxicating cannabinoid that converts to delta-9 when smoked. The change is technical. The impact is brutal. As the Dallas Observer reported, virtually all smokable hemp flower will become illegal under this new standard, effective March 31. One hemp store operator told Yahoo News he'll have to close entirely. Another, who feared public retaliation, said the rules will "effectively shut down our businesses overnight."

💰 MONEY MOVES The Texas Hemp Business Council estimates the industry generates $10-12 billion annually and employs over 50,000 Texans. Mark Bordas, the council's executive director, was direct: "You're talking about shuttering stores… you're talking about major market disruption." Some retailers are bracing for 60-70% revenue declines within weeks. This isn't regulatory fine-tuning—it's an industry collapse. The irony? Hemp-derived intoxicating drinks and edibles remain legal under the new rules. So consumers won't lose access to intoxicating hemp products; they'll just be forced to switch from the product format that dominates retail sales. According to the Austin American-Statesman, the regulation also raises licensing fees—$5,000 annually for retailers, $10,000 for manufacturers—ostensibly to cover regulatory costs.

Texas isn't alone. Ohio is preparing a similar hemp ban affecting CBD stores and breweries, according to the Columbus Dispatch. South Carolina is gauging public opinion on whether to ban intoxicating hemp products entirely, as reported by The State. And federal lawmakers are considering a sweeping national ban, according to the Dallas Observer. The pattern is clear: regulatory bodies are moving in lockstep to eliminate legal access to intoxicating hemp products.

Here's where it gets weird. Heather Fazio, director of the Texas Cannabis Policy Center, acknowledged the regulation might actually push consumers toward illegal markets. the Dallas Observer noted her concern: "Effectively, this is going to ban hemp flower from the legal marketplace… changing to these unreasonably restrictive testing standards would push this marketplace underground, handing it over to illicit operators because legitimate businesses can no longer sell it. That means that products are going to be untested." So the stated goal is consumer protection and harm prevention. The practical outcome is driving a multi-billion-dollar market away from regulated businesses and toward the black market, where testing disappears, quality control vanishes, and consumer safety actually declines. 🔎 DOUBLE STANDARD WATCH Cannabis remains Schedule I while alcohol—responsible for approximately 95,000 deaths per year in the United States—is advertised during every football game and sold in every grocery store. Why are we banning a zero-overdose-death product while the substance that kills tens of thousands remains the nation's favorite legal intoxicant?

🤔 THINK ABOUT IT These bans claim to protect consumers and children. Yet the substance actually killing America's teenagers remains alcohol—the #1 drug-related killer of young people. Meanwhile, the plant with zero recorded overdose deaths in human history is being systematically removed from legal retail. If protection is the goal, shouldn't we be regulating what's proven dangerous rather than eliminating what's proven safe? Texas had a $5.5 billion hemp economy three weeks ago. South Carolina is asking citizens to vote on ending theirs. Ohio is watching its CBD industry collapse. And the federal government is circling. The question isn't whether these bans will happen. The question is whether anyone's asking themselves why we're choosing prohibition over regulation, underground markets over legal ones, and continuing a pattern of cannabis policy that contradicts every principle we claim to care about.

# THC in Science: Memory, Medicine, and the Policy Contradiction Nobody's Talking About

Researchers at Washington State University just dropped one of the most comprehensive studies on cannabis and memory ever conducted, and the findings are straightforward: THC doesn't just make you forget things—it literally creates false memories. According to the Journal of Psychopharmacology study, participants who consumed THC were significantly more likely to recall words they were never shown and struggled with everyday memory tasks like remembering appointments or conversations. What surprised the researchers most? Even moderate doses—20 milligrams—caused the same memory disruption as double that amount. Associate Professor Carrie Cuttler noted this is the first study to examine multiple memory systems simultaneously, finding that THC broadly disrupts most of them. Out of 21 different memory tests, cannabis affected performance on 15 of them. This matters because it's not just about forgetting your grocery list; it's about your brain literally reconstructing reality.

But here's where the conversation gets interesting. While THC is reshaping how your brain files information, the non-psychoactive compounds in cannabis are reshaping how we think about disease. Researchers at the Hebrew University of Jerusalem, publishing in the British Journal of Pharmacology, found that CBD and CBG—the compounds that don't get you high—can significantly reduce liver fat and improve metabolic health. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects roughly one-third of the global adult population, making this discovery huge. The mechanism? CBD and CBG trigger a "metabolic remodeling" process that increases phosphocreatine molecules and activates cathepsin enzymes, essentially cleaning out the liver's toxic buildup. Lead researcher Joseph Tam called it a new pathway to understanding how cannabis compounds enhance both energy function and cellular cleanup. 🚀 THIS IS COOL The compounds are literally teaching the organ to manage itself better—without any of the intoxication or false memory creation that THC brings.

The cancer research is equally striking. 🚀 THIS IS COOL A new study published in Current Drug Discovery Technologies found that CBD interacts strongly with four proteins central to breast cancer progression—CDK6, BCL2, MMP2, and VEGFR2. Researchers from universities in India used molecular docking to compare CBD's binding affinity against standard cancer inhibitors like palbociclib and axitinib, and CBD performed comparably. What makes this genuinely transformative is that breast cancer isn't driven by a single pathway; it's a multi-system disease involving cell proliferation, resistance to death signals, metastasis, and tumor blood vessel formation. A single compound that targets multiple pathways simultaneously could fundamentally change how we approach treatment. The research is computational for now—meaning it needs lab and animal testing before human trials—but the pattern is becoming undeniable: cannabis compounds are hitting biological targets that pharmaceutical companies have been chasing for decades.

Now pivot to older adults with chronic pain, where the contrast between THC and CBD becomes crystal clear. A study published in the Journal of Pain Research analyzed real-world data from Germany's Pain e-Registry, comparing 484 patients age 65+ using CBD-dominant full-spectrum extracts against 484 using pure THC. Both worked—but the differences were dramatic. CBD-dominant extracts produced significantly better outcomes across every major category: average daily pain intensity, pain-related disability, nighttime sleep, daily functioning, quality of life, and emotional distress. But here's the critical part: only 15.5% of the CBD group reported adverse drug reactions compared to 35.7% in the pure THC group. Treatment discontinuation due to side effects? 5.6% for CBD versus 19.2% for THC. The CBD group hit the primary success benchmark at 85.7%, while the THC group barely reached 21.9%. 🔎 DOUBLE STANDARD WATCH "Cannabis remains Schedule I while millions of seniors struggle to access a plant compound that outperforms prescription alternatives in safety and efficacy. Why are we still treating pain management like a legal question instead of a health question?"

💰 MONEY MOVES Medicare is about to wade into this territory directly. A proposal expected to launch as early as April 2026 would provide Medicare beneficiaries with up to $500 annually to purchase CBD products, targeting chronic pain, sleep disorders, and anxiety while potentially reducing reliance on opioids and benzodiazepines. That's a signal that policy is finally catching up to what the science already knows. Meanwhile, delta-8 THC products are exploding in popularity—gummies, vapes, pre-rolls, tinctures—often in youth-oriented packaging and marketed as "legal" alternatives. But Medical Xpress reported that labeling is inconsistent and doses are often dangerously high, a perfect example of what happens when the market moves faster than regulation.

There's also emerging evidence that recreational cannabis legalization actually displaces illegal markets. A study from Columbia University Mailman School of Public Health found that adopting recreational cannabis laws—not just medical ones—helps shrink the illegal cannabis market in U.S. states. Translation: legalization works. It undercuts the black market, puts revenue in government coffers, and removes the criminal records that have devastated communities for fifty years. And yet federal policy remains frozen at Schedule I, a classification that has persisted for over five decades despite mounting evidence of medical value and a complete absence of overdose deaths in recorded history.

🤔 THINK ABOUT IT We've got a plant that kills zero people, shows genuine therapeutic promise against liver disease, cancer, and pain, and works better than many pharmaceutical alternatives—all while remaining federally illegal. Meanwhile, alcohol kills approximately 95,000 Americans annually and prescription opioids kill over 16,000 per year, yet both remain not just legal but heavily marketed and covered by insurance. The science is moving at light speed. The policy is stuck in 1970. When does the absurdity become impossible to ignore?

Texas is about to ban smokable cannabis products in just over two weeks, and the move is shaping up to be a masterclass in regulatory contradiction. On March 31, virtually all smokable hemp and THC products will become illegal to sell across the state—not because lawmakers passed a ban, but because the Texas Department of State Health Services rewrote the rules for how THC gets measured. According to Marijuana Moment, the agency finalized the regulations after receiving more than 1,400 comments urging revisions, many of them opposing the very changes that are now set to take effect.

Here's where it gets interesting: the new rules adopt a "total THC" standard that counts THCA—a non-psychoactive cannabinoid that converts to delta-9 THC when heated—as if it were already intoxicating. Under Texas's 2019 hemp law, products containing 0.3% or less delta-9 THC by dry weight were legal. That loophole allowed manufacturers to cultivate plants loaded with THCA, which breaks down into THC at roughly an 88% conversion rate when smoked. The new regulation closes that loophole by counting the potential conversion. 🔎 DOUBLE STANDARD WATCH Cannabis remains Schedule I while alcohol—responsible for 95,000 deaths per year—sits in every grocery store aisle and gets advertised during football games. Meanwhile, a plant with zero recorded overdose deaths in human history is being phased out of the legal market. How exactly does that protect public health?

💰 MONEY MOVES The fallout is massive. According to the Texas Tribune, hemp businesses are bracing for police raids to spike—more than 15 have already occurred in the last two years—and industry leaders warn of devastating economic consequences. Mark Bordas, executive director of the Texas Hemp Business Council, told Yahoo News that the industry generates $10-12 billion annually and employs over 50,000 Texans. Individual store operators predict 60-70% revenue declines within three weeks. One unnamed retailer told Yahoo he'll have to close entirely: "For many small retailers across Texas—including my own vape shop—these rules will effectively shut down our businesses overnight." The state did lower licensing fees from what was initially proposed—retailers will pay $5,000 annually instead of $20,000, and manufacturers $10,000 instead of $25,000—but that's cold comfort when your primary product becomes illegal.

The rules aren't entirely one-sided. Edible hemp products and infused drinks will remain legal under stricter packaging and testing requirements, and the medical marijuana program is actually expanding, with nine new licenses already approved and three more expected before April 1, according to Marijuana Moment. But for the smokable market, the impact is severe. Heather Fazio, director of the Texas Cannabis Policy Center, told the Dallas Observer that the total THC standard will effectively push the entire market underground: "Effectively, this is going to ban hemp flower from the legal marketplace. Consumers enjoy the natural product with naturally occurring levels of THC in the hemp flower, and changing to these unreasonably restrictive testing standards would push this marketplace underground, handing it over to illicit operators because legitimate businesses can no longer sell it. That means that products are going to be untested."

🚀 THIS IS COOL Here's the thing that actually makes sense about the regulations: they include real consumer protections—age limits on sales, stricter testing and labeling requirements, record-keeping standards. Those are the pieces that work. But they're bundled with a total THC ban that appears designed to eliminate the entire smokable category. Gov. Greg Abbott issued an executive order in September 2025 directing these changes after the legislature couldn't agree on whether to regulate or ban THC products outright. Abbott then vetoed a broader ban bill—Senate Bill 3, backed by officials who called THC products "poison"—only to have his appointed agencies essentially accomplish the same goal through regulatory action.

🤔 THINK ABOUT IT If smokable hemp truly represents a public health threat, then why is alcohol—which kills 95,000 Americans per year—sold in every convenience store and advertised during major sporting events? Why do prescription opioids, which kill over 16,000 people annually, remain widely prescribed while a plant with zero overdose deaths in recorded history gets phased out of the legal market? The answer isn't about health. It's about control. And in just 16 days, Texas is about to prove it.